| Bioactivity | STK17A/B-IN-1 (compound 9) is an orally active, potent, and selective STK17A/B inhibitor with an IC50 of 23 nM against STK17A. STK17A/B-IN-1 can be used for study of cancer[1]. |
| CAS | 3002038-21-0 |
| Formula | C26H27N7O |
| Molar Mass | 453.54 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Chaudhry S, et al. Potent, Selective, and Orally Bioavailable Quinazoline-Based STK17A/B Dual Inhibitors. ACS Med Chem Lett. 2024;15(6):945-949. Published 2024 May 20. |
STK17A/B-IN-1
CAS: 3002038-21-0 F: C26H27N7O W: 453.54
STK17A/B-IN-1 (compound 9) is an orally active, potent, and selective STK17A/B inhibitor with an IC50 of 23 nM against S
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.